Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine · Delayed Price · Currency is JOD 3.500
+0.120 (3.55%)
At close: Dec 2, 2025
PEX:BJP Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 12.05 | 9.66 | 9.61 | 10.77 | 9.76 | 8.69 | Upgrade | |
Revenue Growth (YoY) | 32.68% | 0.54% | -10.73% | 10.37% | 12.26% | -1.41% | Upgrade |
Cost of Revenue | 7.4 | 6.48 | 6.15 | 6.75 | 6.96 | 6.12 | Upgrade |
Gross Profit | 4.66 | 3.19 | 3.46 | 4.02 | 2.79 | 2.57 | Upgrade |
Selling, General & Admin | 1.4 | 1.26 | 1.3 | 1.66 | 1.69 | 1.52 | Upgrade |
Operating Expenses | 1.4 | 1.26 | 1.3 | 1.66 | 1.69 | 1.52 | Upgrade |
Operating Income | 3.26 | 1.92 | 2.16 | 2.35 | 1.11 | 1.05 | Upgrade |
Interest Expense | -0.11 | -0.11 | -0.11 | -0.12 | -0.09 | -0.07 | Upgrade |
Currency Exchange Gain (Loss) | -0.18 | 0.06 | -0.1 | 0.12 | 0.03 | -0.11 | Upgrade |
Other Non Operating Income (Expenses) | 0.01 | - | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade |
Pretax Income | 2.98 | 1.87 | 1.96 | 2.36 | 1.05 | 0.88 | Upgrade |
Income Tax Expense | 0.26 | 0.12 | 0.12 | 0.38 | 0.18 | 0.14 | Upgrade |
Net Income | 2.72 | 1.76 | 1.84 | 1.98 | 0.87 | 0.75 | Upgrade |
Net Income to Common | 2.72 | 1.76 | 1.84 | 1.98 | 0.87 | 0.75 | Upgrade |
Net Income Growth | 112.01% | -4.42% | -7.26% | 127.43% | 16.87% | -45.33% | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Change (YoY) | -0.63% | - | - | - | - | - | Upgrade |
EPS (Basic) | 0.39 | 0.25 | 0.26 | 0.28 | 0.12 | 0.11 | Upgrade |
EPS (Diluted) | 0.39 | 0.25 | 0.26 | 0.28 | 0.12 | 0.11 | Upgrade |
EPS Growth | 113.36% | -4.42% | -7.26% | 127.43% | 16.87% | -45.33% | Upgrade |
Free Cash Flow | 1.68 | 0.22 | 0.67 | 2.81 | 0.27 | -0.1 | Upgrade |
Free Cash Flow Per Share | 0.24 | 0.03 | 0.10 | 0.40 | 0.04 | -0.01 | Upgrade |
Dividend Per Share | - | 0.120 | 0.100 | 0.100 | 0.100 | 0.100 | Upgrade |
Dividend Growth | - | 20.00% | - | - | - | -33.33% | Upgrade |
Gross Margin | 38.63% | 32.99% | 36.00% | 37.31% | 28.63% | 29.60% | Upgrade |
Operating Margin | 27.03% | 19.91% | 22.45% | 21.87% | 11.35% | 12.12% | Upgrade |
Profit Margin | 22.55% | 18.17% | 19.11% | 18.40% | 8.93% | 8.58% | Upgrade |
Free Cash Flow Margin | 13.97% | 2.26% | 6.97% | 26.14% | 2.75% | -1.11% | Upgrade |
EBITDA | 5.71 | 2.6 | 3.26 | 3.31 | 2.12 | 1.98 | Upgrade |
EBITDA Margin | 47.34% | 26.95% | 33.90% | 30.70% | 21.69% | 22.77% | Upgrade |
D&A For EBITDA | 2.45 | 0.68 | 1.1 | 0.95 | 1.01 | 0.93 | Upgrade |
EBIT | 3.26 | 1.92 | 2.16 | 2.35 | 1.11 | 1.05 | Upgrade |
EBIT Margin | 27.03% | 19.91% | 22.45% | 21.87% | 11.35% | 12.12% | Upgrade |
Effective Tax Rate | 8.78% | 6.18% | 6.29% | 16.22% | 17.21% | 15.49% | Upgrade |
Advertising Expenses | - | 0.03 | 0.04 | 0.08 | 0.07 | 0.07 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.